WEE1 and ovarian cancer: Stable depletion of SKP2, CUL1, or CDK2 rescued sensitivity to Wee1 inhibition in breast and ovarian cancer cell lines, indicating that cancer patients with overexpression of these G1/S regulatory genes could respond robustly to Wee1 inhibitors (25).